Capital Bank & Trust’s Boston Scientific BSX Stock Holding History

Capital Bank & Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,019	Closed	-$252K	–	367
2020 Q4	$252K	Buy	+7,019	New	+$253K	﹤0.01%	320
2020 Q2	–	Sell	-1,848	Closed	-$60K	–	345
2020 Q1	$60K	Sell	1,848 -67	-3%	-$2.62K	﹤0.01%	392
2019 Q4	$87K	Sell	1,915 -186	-9%	-$7.78K	﹤0.01%	376
2019 Q3	$85K	Buy	2,101 +103	+5%	+$4.36K	﹤0.01%	382
2019 Q2	$86K	Hold	1,998	–	–	﹤0.01%	374
2019 Q1	$77K	Hold	1,998	–	–	﹤0.01%	366
2018 Q4	$71K	Hold	1,998	–	–	﹤0.01%	380
2018 Q3	$77K	Sell	1,998 -1,200	-38%	-$41.9K	﹤0.01%	394
2018 Q2	$105K	Buy	3,198 +1,380	+76%	+$41.6K	﹤0.01%	349
2018 Q1	$50K	Hold	1,818	–	–	﹤0.01%	384
2017 Q4	$45K	Hold	1,818	–	–	﹤0.01%	430
2017 Q3	$53K	Hold	1,818	–	–	﹤0.01%	374
2017 Q2	$50K	Buy	+1,818	New	+$48.2K	﹤0.01%	354

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Capital Bank & Trust's BSX Position: Q1 2021 in Review

Capital Bank & Trust sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 7,019 shares — an estimated $252K sold.

Capital Bank & Trust first reported a position in BSX in Q2 2017 and held it in 13 quarters. The position peaked at $252K in Q4 2020. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

Capital Bank & Trust reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
Capital Bank & Trust sold 7,019 Boston Scientific shares in Q1 2021, an estimated $252K.
Capital Bank & Trust first reported a position in Boston Scientific in Q2 2017 and held it in 13 quarters.
Capital Bank & Trust's Boston Scientific position peaked at $252K in Q4 2020.
830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Capital Bank & Trust's 13F filing for Q1 2021, filed 14 May 2021.